HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.

AbstractBACKGROUND:
Duchenne muscular dystrophy is a fatal cardiac and skeletal muscle disease resulting from mutations in the dystrophin gene. We have previously demonstrated that a dystrophin-associated protein, sarcospan (SSPN), ameliorated Duchenne muscular dystrophy skeletal muscle degeneration by activating compensatory pathways that regulate muscle cell adhesion (laminin-binding) to the extracellular matrix. Conversely, loss of SSPN destabilized skeletal muscle adhesion, hampered muscle regeneration, and reduced force properties. Given the importance of SSPN to skeletal muscle, we investigated the consequences of SSPN ablation in cardiac muscle and determined whether overexpression of SSPN into mdx mice ameliorates cardiac disease symptoms associated with Duchenne muscular dystrophy cardiomyopathy.
METHODS AND RESULTS:
SSPN-null mice exhibited cardiac enlargement, exacerbated cardiomyocyte hypertrophy, and increased fibrosis in response to β-adrenergic challenge (isoproterenol; 0.8 mg/day per 2 weeks). Biochemical analysis of SSPN-null cardiac muscle revealed reduced sarcolemma localization of many proteins with a known role in cardiomyopathy pathogenesis: dystrophin, the sarcoglycans (α-, δ-, and γ-subunits), and β1D integrin. Transgenic overexpression of SSPN in Duchenne muscular dystrophy mice (mdx(TG)) improved cardiomyofiber cell adhesion, sarcolemma integrity, cardiac functional parameters, as well as increased expression of compensatory transmembrane proteins that mediate attachment to the extracellular matrix.
CONCLUSIONS:
SSPN regulates sarcolemmal expression of laminin-binding complexes that are critical to cardiac muscle function and protects against transient and chronic injury, including inherited cardiomyopathy.
AuthorsMichelle S Parvatiyar, Jamie L Marshall, Reginald T Nguyen, Maria C Jordan, Vanitra A Richardson, Kenneth P Roos, Rachelle H Crosbie-Watson
JournalJournal of the American Heart Association (J Am Heart Assoc) Vol. 4 Issue 12 (Dec 23 2015) ISSN: 2047-9980 [Electronic] England
PMID26702077 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Chemical References
  • Carrier Proteins
  • Membrane Proteins
  • Neoplasm Proteins
  • Sspn protein, mouse
  • Creatine Kinase, MB Form
  • Isoproterenol
Topics
  • Animals
  • Cardiomyopathies (etiology, pathology)
  • Carrier Proteins (physiology)
  • Creatine Kinase, MB Form (blood)
  • Echocardiography
  • Fluorescent Antibody Technique
  • Heart (drug effects, physiopathology)
  • Humans
  • Isoproterenol (pharmacology)
  • Male
  • Membrane Proteins (physiology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscular Dystrophy, Duchenne (complications, pathology)
  • Myocardium (pathology)
  • Neoplasm Proteins (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcolemma (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: